Effect of DPP-4(dipeptidyl peptidase-4) inhibitor for coronary plaque in diabetes patients.
Phase of Trial: Phase III
Latest Information Update: 11 Sep 2014
At a glance
- Drugs Vildagliptin (Primary) ; Glimepiride
- Indications Diabetes mellitus; Ischaemic heart disorders
- Focus Pharmacodynamics
- 09 Sep 2014 Status changed from recruiting to discontinued, according to UMIN record.
- 09 Jan 2012 New trial record